Moving forward in uveitis therapy: preclinical to phase II clinical trial drug development.

about

Moving forward in uveitis therapy: preclinical to phase II clinical trial drug development.

Item

http://www.wikidata.org/entity/Q38660708

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Moving forward in uveitis ther ...... inical trial drug development.

@en

type

Item

label

Moving forward in uveitis ther ...... inical trial drug development.

@en

prefLabel

Moving forward in uveitis ther ...... inical trial drug development.

@en

P1476

Moving forward in uveitis ther ...... inical trial drug development.

@en

P2093

Miguel Cordero-Coma

http://www.w3.org/2001/XMLSchema#string

Raquel Salazar-Méndez

http://www.w3.org/2001/XMLSchema#string

Taygan Yilmaz

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

Emerging drugs for uveitis

Intravenous immunoglobulin therapy for resistant ocular Behçet's disease

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation.

Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis

Effects of gold nanoparticles on endotoxin-induced uveitis in rats

Oral vitamins C and E as additional treatment in patients with acute anterior uveitis: a randomised double masked study in 145 patients.

High-efficacy site-directed drug delivery system using sialyl-Lewis X conjugated liposome.

Evaluation of a prednisolone acetate-loaded subconjunctival implant for the treatment of recurrent uveitis in a rabbit model

P304

195-214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2016.1128893

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26640977

http://www.w3.org/2001/XMLSchema#string

P921

uveitis

phase II clinical trial